NCT03872453 Acute Treatment Trial in Adult Subjects With Migraines Status COMPLETED Phase PHASE2/PHASE3
NCT03871439 OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS Status COMPLETED Phase PHASE1
NCT03870919 Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT03864042 Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03861403 A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03861273 A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03860506 Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke Status COMPLETED Phase PHASE1
NCT03854903 WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor Status COMPLETED Phase PHASE1
NCT03854227 A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT03851081 Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia Status WITHDRAWN Phase PHASE1/PHASE2
NCT03850483 Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis Status COMPLETED Phase PHASE2
NCT03848052 Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) Status RECRUITING Phase N/A
NCT03845517 A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Status COMPLETED Phase PHASE2
NCT03842163 Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology Status COMPLETED Phase N/A
NCT03839498 Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03839446 Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy Status COMPLETED Phase PHASE2
NCT03839355 Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation Status TERMINATED Phase PHASE3